Phòng thí nghiệm tham chiếu quốc gia toàn cầu
Bộ dữ liệu tổng hợp bền vững về phòng thí nghiệm tham chiếu quốc gia theo quốc gia/vùng và thời gian; các chỉ tiêu thành phần là dimensions/metrics trong cùng data product.
Mã lược đồ chuẩn hoábop.facility-registry (v2.2.0)
Quy mô bản ghi58 dòng dữ liệu
| Mã định danh | Tên / chỉ tiêu | Loại cơ sở | Địa bàn | Đơn vị vận hành | Trạng thái | Công suất | Đơn vị | Địa chỉ | URL nguồn |
|---|---|---|---|---|---|---|---|---|---|
| it-spallanzani | National Institute for Infectious Diseases "L. Spallanzani" | Italy; WHO region EURO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| se-public-health-agency | Public Health Agency Of Sweden | Sweden; WHO region EURO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| es-carlos-iii | Instituto de la Salud "Carlos III" | Spain; WHO region EURO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| mg-pasteur-madagascar | Institut Pasteur Madagascar | Madagascar; WHO region AFRO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| ca-national-microbiology-institute | National Microbiology Institute, Public Health Agency of Canada | Canada; WHO region PAHO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| cl-laboratorio-biomedico-nacional | Laboratorio Biomedico Nacional de Referencia | Chile; WHO region PAHO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| kh-pasteur-cambodia | Institut Pasteur du Cambodge | Cambodia; WHO region WPRO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| hk-public-health-laboratory-services | Public Health Laboratory Services Branch, Centre for Health Protection | China PDR (Hong Kong); WHO region WPRO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| id-national-health-biology-laboratory | National Health Biology Laboratory, Ministry of Health | Indonesia; WHO region WPRO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| ph-research-institute-tropical-medicine | Research Institute for Tropical Medicine | Philippines; WHO region WPRO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| kr-kdca | Korea Disease Control and Prevention Agency | Republic of Korea; WHO region WPRO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| sg-communicable-disease-agency | Communicable Disease Agency | Singapore; WHO region WPRO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| dz-pasteur-algeria | Institut Pasteur of Algeria | Algeria; WHO region AFRO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| vn-oxford-clinical-research-unit | Oxford University Clinical Research Unit | Vietnam; WHO region WPRO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| it-izs-abruzzo-molise | Insitituto Zooprofilattico Sperimentale dell'Abruzzo e Molise | Italy; WHO region EURO | CoViNet reference laboratory — Animal | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| ae-abu-dhabi-agriculture-food-safety | Abu Dhabi Agriculture and Food Safety Authority, | UAE; WHO region EMRO | CoViNet reference laboratory — Animal | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| fr-ird | Institut de Recherche pour le Developpment (IRD) | France; WHO region EURO | CoViNet reference laboratory — Animal | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| us-uc-davis-vet-school | UC Davis School of Veterinary Medicine - Pathology, Microbiology, and Immunology | USA; WHO region PAHO | CoViNet reference laboratory — Animal | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| lk-medical-research-institute | Medical research insititue - Sri Lanka | Sri Lanka; WHO region SEARO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| mn-national-center-communicable-diseases | National Center for Communicable Diseases (NCCD | Mongolia; WHO region WPRO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| za-stellenbosch-nhls-tygerber | Division of Medical Virology, University of Stellenbosch / National Health Laboratory Service Tygerber | South Africa; WHO region AFRO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| ng-ncdc | Nigeria Centre for Disease Control and Prevention | Nigeria; WHO region AFRO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| vn-nihe | National Institute of Hygiene and Epidemiology | Vietnam; WHO region WPRO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| gh-national-public-health-reference-laboratory | National Public Health Reference Laboratory | Ghana; WHO region AFRO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| vn-pasteur-hcmc | Pasteur institute in Ho Chi Minh City | Vietnam; WHO region WPRO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| ch-eawag | Eawag, Swiss Federal Institute for Aquatic Science and Technology | Switzerland; WHO region EURO | CoViNet reference laboratory — Environment | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| au-peter-doherty-institute | The Peter Doherty Institute for Infection and Immunity | Australia; WHO region WPRO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| br-fiocruz | Fundação Oswaldo Cruz | Brazil; WHO region AMRO/PAHO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| fr-institut-pasteur | Institut Pasteur | France; WHO region EURO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| fr-hospices-civils-lyon | Hospices Civils de Lyon | France; WHO region EURO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| de-charite-berlin | Charité - Universitätsmedizin Berlin | Germany; WHO region EURO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| gh-noguchi-memorial | Noguchi Memorial Institute for Medical Research | Ghana; WHO region AFRO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| hk-university-hong-kong | The University of Hong Kong | Hong Kong SAR, China; WHO region WPRO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| in-thsti | Translational Health Science and Technology Institute | India; WHO region SEARO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| in-niv-pune | Indian Council of Medical Research-National Institute of Virology Pune | India; WHO region SEARO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| jp-niid | National Institute of Infectious Diseases | Japan; WHO region WPRO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| mx-inDRE | Instituto De Diagnostico Y Referencia Epidemiologicos, Dr Manuel Martinez Baez | Mexico; WHO region AMRO/PAHO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| pk-national-institute-health | National Institute of Health, Pakistan | Pakistan; WHO region EMRO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| ru-vector | Federal Budgetary Institution of Science "State Scientific Centre of Virology and Biotechnology "Vector" of the Federal Service for Supervision of Consumer Rights Protection and Human Welfare | Russian Federation; WHO region EURO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| sn-pasteur-dakar | Institut Pasteur de Dakar | Senegal; WHO region AFRO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| za-africa-health-research-institute | Africa Health Research Institute | South Africa; WHO region AFRO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| za-nicd | National Institute for Communicable Diseases | South Africa; WHO region AFRO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| ch-geneva-ivi | University Hospitals of Geneva / Institute of Virology and Immunology, Mittelhäusern | Switzerland; WHO region EURO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| th-chulalongkorn | King Chulalongkorn Memorial Hospital, Chulalongkorn University | Thailand; WHO region SEARO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| th-national-institute-health | National Institute of Health, Thailand | Thailand; WHO region SEARO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| nl-erasmus-medical-centre | Erasmus Medical Centre | Netherlands; WHO region EURO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| nl-rivm | National Institute for Public Health and the Environment | Netherlands; WHO region EURO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| ug-virus-research-institute | Uganda Virus Research Institute | Uganda; WHO region AFRO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| ae-reference-lab-infectious-disease | Reference Laboratory Infectious Disease | United Arab Emirates; WHO region EMRO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| gb-ukhsa | UK Health Security Agency | United Kingdom of Great Britain and Northern Ireland; WHO region EURO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| us-emory-university | Emory University | United States of America; WHO region PAHO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| us-cdc | Centers for Disease Control and Prevention (CDC) | United States of America; WHO region PAHO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| us-ohio-state-fao-reference-centre | Ohio State University (FAO reference centre) | United States of America; WHO region PAHO | CoViNet reference laboratory — Animal | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| sg-public-utilities-board-national-environment-agency | Public Utilities Board/National Environment Agency Singapore | Singapore; WHO region WPRO | CoViNet reference laboratory — Environment | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| de-friedrich-loeffler-institute | Frederic Loefller Institute (WOAH reference centre) | Germany; WHO region EURO | CoViNet reference laboratory — Animal | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| nl-kwr-water-research-institute | KWR Water Research Institute | Kingdom of the Netherlands; WHO region EURO | CoViNet reference laboratory — Environment | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| in-csir-neeri | CSIR - National Environmental Engineering Research Institute | India; WHO region SEARO | CoViNet reference laboratory — Environment | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |
| gb-francis-crick-institute | Francis Crick Institute | United Kingdom of Great Britain and Northern Ireland; WHO region EURO | CoViNet reference laboratory — Human | — | — | — | — | — | https://cdn.who.int/media/docs/default-source/documents/epp/covinet-newsletters/covinet-reference-laboratories_march2026.pdf?sfvrsn=41f72389_4 |